Lithium’s Emerging Role in the Treatment of Refractory Major Depressive Episodes: Augmentation of Antidepressants | Zendy

Michael Bauer | Zendy; Mazda Adli | Zendy; Tom Bschor | Zendy; Maximilian Pilhatsch | Zendy; Andrea Pfennig | Zendy; Johanna Sasse | Zendy; Rita Schmid | Zendy; Ute Lewitzka | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lithium’s Emerging Role in the Treatment of Refractory Major Depressive Episodes: Augmentation of Antidepressants

Author(s) -

Michael Bauer,

Mazda Adli,

Tom Bschor,

Maximilian Pilhatsch,

Andrea Pfennig,

Johanna Sasse,

Rita Schmid,

Ute Lewitzka

Publication year - 2010

Publication title -

neuropsychobiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.71

H-Index - 83

eISSN - 1423-0224

pISSN - 0302-282X

DOI - 10.1159/000314308

Subject(s) - placebo , lithium (medication) , antidepressant , meta analysis , odds ratio , medicine , randomized controlled trial , depression (economics) , psychiatry , psychology , alternative medicine , pathology , hippocampus , economics , macroeconomics

The late onset of therapeutic response and a relatively large proportion of nonresponders to antidepressants remain major concerns in clinical practice. Therefore, there is a critical need for effective medication strategies that augment treatment with antidepressants.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research